European Regulatory Watch

January 02, 2024

The EHDS aims to increase access to health data, but how will it impact pharma?

December 02, 2023

What does the 2024 VPAS mean for pharma?

November 02, 2023

The EU’s AI Act is set to become the world’s first comprehensive legal framework for artificial intelligence.

September 28, 2023

The new framework will position the UK as an attractive prospect for new medicine manufacturers.

September 02, 2023

The ACT EU initiative aims to develop the European Union further as a competitive centre for innovative clinical research.

August 02, 2023

What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?

July 02, 2023

Changes to PRIME scheme are set to drive greater harmonization across major pharmaceutical markets.

June 02, 2023

What implications will EMA’s recent regulatory reform have on pharma?

May 02, 2023

A strategy on cyber resilience for health and social care organizations has been set out by the UK government.

April 02, 2023

Proposed regulatory changes signal a major overhaul of legislation governing pharmaceuticals and healthcare in Spain.